State-of-the-art laboratories located within the NEOMED Institute’s Biologics and Vaccines hub in Laval (just North of the Montreal area)

Our facility is equipped with the latest platform technologies to conduct cutting-edge analyses of host responses to vaccines under GCLP conditions. Supported by an integrated system of laboratory robots and automated analyzers, our platforms allow high-throughput testing of clinical specimens to facilitate accelerated development of vaccines and immunotherapeutics from early to late-stage human clinical trials. Our state-of-the-art laboratories include BSL 2 and BSL 3 facilities to conduct testing involving handling of dangerous pathogens.

  • Occupies 17,000 sq. ft. of lab and office space
  • Over 60 scientists and lab technicians
  • Over 15 years of experience supporting prophylactic and therapeutic vaccine development
  • More than 30 assays currently being performed
  • Over 150,000 results annually
  • Storage capacity of over 500,000 clinical samples


Discover NEOMED-LABS – 360° virtual tour